- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 189-203 of
561 results
1028 Exhibit: AMNEAL 1028 McBride, INT L J MS CARE 4 85 2002
Document
IPR2015-01980, No. 1028 Exhibit - AMNEAL 1028 McBride, INT L J MS CARE 4 85 2002 (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1011 Exhibit: AMNEAL 1011 Christina Caon et al, Randomized, Prospective, Rater...
Document
IPR2015-01980, No. 1011 Exhibit - AMNEAL 1011 Christina Caon et al, Randomized, Prospective, Rater Blinded, Four Year Pilot Study to Compare the Effect of Daily Versus Every Other Day Gl...
|
|
Cite Document
1045 Exhibit: AMNEAL 1045 Tjalf Ziemssen et al, Effects of glatiramer acetate on fa...
Document
IPR2015-01980, No. 1045 Exhibit - AMNEAL 1045 Tjalf Ziemssen et al, Effects of glatiramer acetate on fatigue and days of absence from work in first time treated relapsing remitting multiple scle...
|
|
Cite Document
1029 Exhibit: AMNEAL 1029 Dene Simpson, Adis Drug Evaluation Glatiramer Acet...
Document
IPR2015-01980, No. 1029 Exhibit - AMNEAL 1029 Dene Simpson, Adis Drug Evaluation Glatiramer Acetate A Review of its use in Relapsing Remitting Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1030 Exhibit: AMNEAL 1030 Catherine M Edgar, et al, Lipoatrophy in Patients with ...
Document
IPR2015-01980, No. 1030 Exhibit - AMNEAL 1030 Catherine M Edgar, et al, Lipoatrophy in Patients with Multiple Sclerosis on Glatiramer Acetate (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1038 Exhibit: AMNEAL 1038 CC Ford et al, A prospective open label study of glatira...
Document
IPR2015-01980, No. 1038 Exhibit - AMNEAL 1038 CC Ford et al, A prospective open label study of glatiramer acetate over a decade of continuous use in multiple sclerosis patients (P.T.A.B. Sep...
|
|
Cite Document
1014 Exhibit: AMNEAL 1014 MB Bornstein, Multiple Sclerosis Trial of a Synthetic P...
Document
IPR2015-01980, No. 1014 Exhibit - AMNEAL 1014 MB Bornstein, Multiple Sclerosis Trial of a Synthetic Polypeptide (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1034 Exhibit: AMNEAL 1034 Paul Beringer et al, Clinical Pharmacokinetics and Pha...
Document
IPR2015-01980, No. 1034 Exhibit - AMNEAL 1034 Paul Beringer et al, Clinical Pharmacokinetics and Pharmacodynamics, in REMINGTON (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1053 Exhibit: AMNEAL 1053 Extavia Product Label 2009
Document
IPR2015-01980, No. 1053 Exhibit - AMNEAL 1053 Extavia Product Label 2009 (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1024 Exhibit: AMNEAL 1024 US Patent No 6,342,476
Document
IPR2015-01980, No. 1024 Exhibit - AMNEAL 1024 US Patent No 6,342,476 (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1013 Exhibit: AMNEAL 1013 James R Miller, The importance of early diagnosis of m...
Document
IPR2015-01980, No. 1013 Exhibit - AMNEAL 1013 James R Miller, The importance of early diagnosis of multiple sclerosis (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1054 Exhibit: AMNEAL 1054 Jacobs et al, Intramuscular interferon beta 1a therapy...
Document
IPR2015-01980, No. 1054 Exhibit - AMNEAL 1054 Jacobs et al, Intramuscular interferon beta 1a therapy initiated during a first demyelinating event in multiple sclerosis (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1039 Exhibit: AMNEAL 1039 Frohman, Multiple Sclerosis The Plaque and its Patho...
Document
IPR2015-01980, No. 1039 Exhibit - AMNEAL 1039 Frohman, Multiple Sclerosis The Plaque and its Pathogenesis (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1041 Exhibit: AMNEAL 1041 Peter J Manso et al, Life cycle management of ageing...
Document
IPR2015-01980, No. 1041 Exhibit - AMNEAL 1041 Peter J Manso et al, Life cycle management of ageing pharmaceutical assets (P.T.A.B. Sep. 25, 2015)
|
|
Cite Document
1099 Exhibit: Declaration of Prof Joel Hay Public Version
Document
IPR2015-00644, No. 1099-2 Exhibit - Declaration of Prof Joel Hay Public Version (P.T.A.B. Mar. 22, 2016)
|
|
Cite Document
